Boster Immunoleader

ELISA/assay

Rat IL-17F PicoKine ELISA Kit

EK1136

1 x96 well plate

369 USD

Rat IL-17F PicoKine ELISA Kit

EK1136

369 USD

Sandwich ELISA kit for Quantitative Detection of Rat IL-17F

E.coli, A19-A153

1 x96 well plate

31.2pg/ml-2000pg/ml

<10pg/ml

Sample 1: n=16; Mean(pg/ml): 275; Standard deviation: 12.93; CV(%): 4.7 Sample 2: n=16; Mean(pg/ml): 524; Standard deviation: 32.5; CV(%): 6.2 Sample 3: n=16; Mean(pg/ml): 928; Standard deviation: 52; CV(%): 5.6

Sample 1: n=24; Mean(pg/ml): 352; Standard deviation: 17.6; CV(%): 5 Sample 2: n=24; Mean(pg/ml): 723; Standard deviation: 52.78; CV(%): 7.3 Sample 3: n=24; Mean(pg/ml): 1230; Standard deviation: 83.64; CV(%): 6.8

There is no detectable cross-reactivity with other relevant proteins.

Store at 4˚C for 6 months, at -20˚C for 12 months. Avoid multiple freeze-thaw cycles(Shipped with wet ice.)

This kit is used for quantitative detection of rat IL-17F in cell culture supernates, serum and plasma(heparin, EDTA).

Rat

Catalog number Description Quantity - 96-well plate precoated with anti- rat IL-17F antibody 1 ST0000-10 Lyophilized recombinant rat IL-17F standard 10ng/tubex2 AR1107 Biotinylated anti- rat IL-17F antibody 130ul(dilution 1:100) AR1103 Avidin-Biotin-Peroxidase Complex(ABC) 130ul(dilution 1:100) AR1106-1 Sample diluent buffer 30 ml AR1106-2 Antibody diluent buffer 12ml AR1106-3 ABC diluent buffer 12ml AR1104 TMB color developing agent 10ml AR1105 TMB stop solution 10ml

Interleukin 17F, also called IL17F is involved in the regulation of normal versus aberrant T-cell responses. This gene is mapped to 6p12.2. The protein encoded by this gene is a cytokine that shares sequence similarity with IL17. This cytokine is expressed by activated T cells, and has been shown to stimulate the production of several other cytokines, including IL6, IL8, and CSF2/GM_CSF. This cytokine is also found to inhibit the angiogenesis of endothelial cells and induce endothelial cells to produce IL2, TGFB1/TGFB, and monocyte chemoattractant protein-1. It is suggested that targeting IL17 and IL17F or antagonizing IL17R might mitigate neutrophil-mediated inflammation in CF.

IL17F

Interleukin-17F

interleukin 17F

CANDF6 Cytokine ML 1 Cytokine ML-1 IL 17F IL 24 IL-17F IL-24 Il17f IL17F_HUMAN Interleukin 17F Interleukin 24 Interleukin-17F Interleukin-24 ML 1 ML1

Q5BJ95